More Post from the Author
- Keys Inc. Marks a Strong First Half of 2025 with New Features and Industry Growth
- ITRI Advances Taiwan's 6G Global Partnerships in the EU and the UK
- Global Times: 'Our pursuit of modern economic development must be underpinned by strategic foresight and holistic coordination'
- Yingfa Ruineng, Srdrlebilirlik Yoluyla Fotovoltaik Sektrne Liderlik Etmeyi Hedefleyerek BM Kresel lkeler Szlemesine Katld
- BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- Keys Inc. Marks a Strong First Half of 2025 with New Features and Industry Growth
- ITRI Advances Taiwan's 6G Global Partnerships in the EU and the UK
- Global Times: 'Our pursuit of modern economic development must be underpinned by strategic foresight and holistic coordination'
- Yingfa Ruineng, Srdrlebilirlik Yoluyla Fotovoltaik Sektrne Liderlik Etmeyi Hedefleyerek BM Kresel lkeler Szlemesine Katld
- BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS